PT937038E - Analogos de vitamina d - Google Patents

Analogos de vitamina d

Info

Publication number
PT937038E
PT937038E PT97910261T PT97910261T PT937038E PT 937038 E PT937038 E PT 937038E PT 97910261 T PT97910261 T PT 97910261T PT 97910261 T PT97910261 T PT 97910261T PT 937038 E PT937038 E PT 937038E
Authority
PT
Portugal
Prior art keywords
hydrogen
methylene
substituted
optionally
formula
Prior art date
Application number
PT97910261T
Other languages
English (en)
Inventor
Henrik Pedersen
Martin John Calverley
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of PT937038E publication Critical patent/PT937038E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
PT97910261T 1996-10-30 1997-10-27 Analogos de vitamina d PT937038E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9622590.9A GB9622590D0 (en) 1996-10-30 1996-10-30 Chemical compounds

Publications (1)

Publication Number Publication Date
PT937038E true PT937038E (pt) 2002-09-30

Family

ID=10802170

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97910261T PT937038E (pt) 1996-10-30 1997-10-27 Analogos de vitamina d

Country Status (20)

Country Link
US (1) US6310226B1 (pt)
EP (1) EP0937038B1 (pt)
JP (1) JP3907010B2 (pt)
KR (1) KR100526644B1 (pt)
CN (1) CN1107669C (pt)
AT (1) ATE216361T1 (pt)
AU (1) AU722659B2 (pt)
CA (1) CA2266479C (pt)
CZ (1) CZ290933B6 (pt)
DE (1) DE69712086T2 (pt)
DK (1) DK0937038T3 (pt)
ES (1) ES2173425T3 (pt)
GB (1) GB9622590D0 (pt)
HU (1) HUP9904333A3 (pt)
NZ (1) NZ334328A (pt)
PL (1) PL192660B1 (pt)
PT (1) PT937038E (pt)
RO (1) RO120338B1 (pt)
RU (1) RU2183622C2 (pt)
WO (1) WO1998018759A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001510183A (ja) * 1997-07-17 2001-07-31 エフ.ホフマン−ラ ロシュ アーゲー 側鎖に2つの不飽和結合を有するジホモ−セコ−コレスタン
WO2004046097A1 (en) * 2002-11-18 2004-06-03 Teva Pharmaceutical Industries Ltd. A crystallization method for purification of calcipotriene
CN1934078B (zh) * 2004-03-18 2011-07-06 利奥制药有限公司 维生素d类似物的立体选择性合成
WO2006051106A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
JP5449767B2 (ja) * 2005-04-25 2014-03-19 サイトクロマ インコーポレイテッド 1α,25−ジヒドロキシビタミンD3の低血漿カルシウム上昇性16,23−ジエン−25−オキシムアナログ
AU2007287099A1 (en) 2006-08-25 2008-02-28 Cougar Biotechnology, Inc. Methods for treating cancer comprising the administration of a vitamin D compound and an additional therapeutic agent, and compositions containing the same
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
US20080051375A1 (en) * 2006-08-25 2008-02-28 Auerbach Alan H Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same
KR20090039833A (ko) * 2006-08-29 2009-04-22 테바 파마슈티컬 인더스트리즈 리미티드 비타민 d 및 코르티코스테로이드를 포함하는 약학 조성물
CN102341110B (zh) 2009-01-27 2017-04-12 博格有限责任公司 用于减轻与化疗有关的副作用的维生素d3及其类似物
WO2011002756A2 (en) * 2009-07-01 2011-01-06 Vitamin Derivatives, Inc. Vitamin d compounds and methods for preparing same
IN2012DN02137A (pt) 2009-08-14 2015-08-07 Berg Biosystems Llc
AU2014274099A1 (en) 2013-05-29 2015-12-24 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin D
JP2019522032A (ja) 2016-07-29 2019-08-08 ヤンセン ファーマシューティカ エヌ.ベー. 前立腺癌の治療方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8914963D0 (en) * 1989-06-29 1989-08-23 Leo Pharm Prod Ltd Chemical compounds
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
GB9017890D0 (en) 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
GB9223061D0 (en) * 1992-11-04 1992-12-16 Leo Pharm Prod Ltd Chemical compounds
US5449668A (en) 1993-06-04 1995-09-12 Duphar International Research B.V. Vitamin D compounds and method of preparing these compounds
US5552392A (en) 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds
JP3228488B2 (ja) * 1993-12-24 2001-11-12 株式会社クラレ 20−エピステロイド誘導体およびその製造方法
JPH0888281A (ja) * 1994-09-19 1996-04-02 Fujitsu Ltd 半導体装置
IL118156A (en) * 1995-05-09 2001-08-26 Duphar Int Res Vitamin d compounds, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DE69712086T2 (de) 2002-11-14
CA2266479C (en) 2008-09-23
AU4771797A (en) 1998-05-22
ES2173425T3 (es) 2002-10-16
DE69712086D1 (de) 2002-05-23
PL192660B1 (pl) 2006-11-30
RU2183622C2 (ru) 2002-06-20
KR20000036233A (ko) 2000-06-26
PL333068A1 (en) 1999-11-08
ATE216361T1 (de) 2002-05-15
EP0937038A1 (en) 1999-08-25
US6310226B1 (en) 2001-10-30
HUP9904333A3 (en) 2001-06-28
CZ135899A3 (cs) 1999-07-14
JP2001503403A (ja) 2001-03-13
HUP9904333A2 (hu) 2000-06-28
RO120338B1 (ro) 2005-12-30
CZ290933B6 (cs) 2002-11-13
HK1022298A1 (en) 2000-08-04
CA2266479A1 (en) 1998-05-07
CN1232448A (zh) 1999-10-20
DK0937038T3 (da) 2002-07-15
NZ334328A (en) 2000-09-29
JP3907010B2 (ja) 2007-04-18
KR100526644B1 (ko) 2005-11-08
AU722659B2 (en) 2000-08-10
GB9622590D0 (en) 1997-01-08
WO1998018759A1 (en) 1998-05-07
EP0937038B1 (en) 2002-04-17
CN1107669C (zh) 2003-05-07

Similar Documents

Publication Publication Date Title
EP0648207A1 (en) VITAMIN D DERIVATE.
PT937038E (pt) Analogos de vitamina d
CA2078555A1 (en) Novel vitamin d analogues
FI956108A0 (fi) Uudet D-vitamiinianalogit
PT1023263E (pt) Novos analogos de vitamina d
DK0633878T3 (da) Nye D-vitaminanaloger
NZ332237A (en) Vitamin D analogues
DK0865428T3 (da) Nye vitamin D analoger
EP0662953A1 (en) NEW VITAMIN D ANALOGS
PT944592E (pt) Derivados de vitamina d3
SE8803143D0 (sv) Alternativa energisubstrat
CA2222785A1 (en) Vitamin d analogues